文献速递肝病

自身免疫性肝炎生存期缩短的早期预后因素:一项系统评价与Meta分析

Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-07-23

该研究系统检索Ovid Medline和embase.com截至2024年4月的文献,纳入33项研究,评估44个早期预后因素对自身免疫性肝炎患者死亡或肝移植、肝病相关死亡或肝移植复合终点的影响。Meta分析显示,诊断时肝硬化和治疗应答不充分是风险比最高的显著预测因素,另有多个因素与生存期缩短相关,而基线转氨酶和 albumin 升高为保护因素。

要点

  • 诊断时肝硬化和治疗应答不充分是影响自身免疫性肝炎生存期的最强预后因素。
  • 高龄、非白种人、原发性硬化性胆管炎变异综合征、无症状起病、较高复发率及INR、肌酐、ALP/AST比值和MELD评分升高与生存期缩短相关。
  • 基线转氨酶和albumin水平升高为保护因素。

核心结论

  • 肝硬化诊断时和治疗应答不充分是自身免疫性肝炎生存期缩短影响最大的预后因素,其他危险因素包括高龄、非白种人、原发性硬化性胆管炎变异综合征、无症状起病、较高复发率以及INR、肌酐、ALP/AST比值和MELD评分升高,而基线转氨酶和albumin升高为保护因素。

研究设计与样本

  • 系统评价与Meta分析,检索Ovid Medline和embase.com截至2024年4月,纳入33项研究,至少3项研究报道同一因素时进行Meta分析,采用GRADE评估证据确定性。

主要发现

  • 诊断时肝硬化(HR 3.21;95%CI 2.38-4.34)和治疗应答不充分(HR 4.35;95%CI 2.5-7.58)是风险比最高的显著预测因素。
  • 其他与生存期缩短相关的因素包括高龄、非白种人、原发性硬化性胆管炎变异综合征、无症状起病、较高复发率、INR升高、肌酐升高、ALP/AST比值升高和MELD评分升高。
  • 基线转氨酶和albumin水平升高为保护因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Autoimmune hepatitis (AIH) is a severe, life-threatening condition for some patients. This systematic review aimed to identify and rank early prognostic factors associated with reduced survival in AIH. METHODS: A systematic search was conducted in Ovid Medline and embase.com up to April 2024 for identifying early prognostic factors for the combined endpoints of death or liver transplantation and liver-related death or liver transplantation. Overview tables of prognostic factors were constructed to outline the number of studies, the respective effect direction, and the statistical significance. Meta-analysis was performed if at least 3 studies reported on a factor. The level of certainty in evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) guideline. RESULTS: Thirty-three studies were included, and 44 prognostic factors were investigated in at least 2 studies. Cirrhosis at diagnosis (hazard ratio [HR], 3.21; 95% confidence interval [CI], 2.38-4.34) and insufficient response to therapy (HR, 4.35; 95% CI, 2.5-7.58) were significant predictors with the highest risk ratios. Additional factors associated with reduced survival include advanced age, non-Caucasian ethnicity, variant syndrome with primary sclerosing cholangitis, asymptomatic presentation, higher relapse rates and elevated international normalized ratio, creatinine, alkaline phosphatase/aspartate aminotransferase ratio, and Model for End-stage Liver Disease score. Protective factors include elevated baseline levels of aminotransferases and albumin levels. CONCLUSIONS: Cirrhosis and insufficient treatment response are the prognostic factors with the highest impact on reduced survival in AIH. Other risk factors include advanced age, non-Caucasian ethnicity, primary sclerosing cholangitis-variant syndrome, asymptomatic presentation, higher relapse rates and elevated international normalized ratio, creatinine, alkaline phosphatase/aspartate aminotransferase ratio, and Model for End-stage Liver Disease score, whereas elevated baseline aminotransferases and albumin are protective.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Slooter CD, Troyer IDM, van den Brand FF, et al. Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis. Clin Gastroenterol Hepatol. 2025. PMID: 40712714. doi:10.1016/j.cgh.2025.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。